LINXIS B V has a total of 29 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are YUYU PHARMA INC, TRIFOILIUM APS and AZTHERAPIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 5 | |
#5 | Canada | 3 | |
#6 | Netherlands | 3 | |
#7 | China | 1 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Sijbrandi Niels Jurriaan | 26 |
#2 | Houthoff Hendrik Jan | 26 |
#3 | Van Dongen Augustinus Antonius Maria Silvester | 23 |
#4 | Waalboer Dennis Christian Johannes | 19 |
#5 | Kok Robbert Jan | 8 |
#6 | Buwalda Sytze Jan | 8 |
#7 | Muns Joey Armand | 7 |
#8 | Steverink Paulus Johannes Gerardus Maria | 6 |
#9 | Merkul Eugen | 6 |
#10 | Niels Jurriaan Sijbrandi | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020185069A1 | Internalizing binding molecules targeting receptors involved in cell proliferation or cell differentiation | |
NL2020121B1 | Platinum-based functional moieties for preparing cell targeting conjugates | |
NL2020120B1 | Methods for preparing cell targeting conjugates and conjugates obtainable by said methods | |
CA3026815A1 | Cell targeting conjugates | |
NL2014423B1 | Method for removing weakly bound functional moieties from cell targeting conjugates. | |
NZ742661A | Method for preparing cell targeting conjugates, and the complexes obtained | |
EP2800587A2 | Method for preparing cell targeting conjugates, and the complexes obtained |